# REX AMERICAN RESOURCES Corp: financial statements, quarterly

REX · NYSE · CIK 744187 · [Materials](/sectors/materials.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/rex.md) · [Financials](/companies/rex/financials.md) · [Filings](/companies/rex/filings.md) · [Insiders](/companies/rex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [221](/filings/0000930413-24-003270.md) | [188 d](/filings/0000930413-26-000937.md) | [161](/filings/0000930413-25-001941.md) | [148](/filings/0000930413-25-002856.md) | [175](/filings/0000930413-25-003566.md) | [158 d](/filings/0000930413-26-000937.md) | [158](/filings/0000930413-26-001786.md) | [159](/filings/0000930413-26-002814.md) | [176](/filings/0000930413-25-003566.md) | [158 d](/filings/0000930413-26-000937.md) | [156](/filings/0000930413-26-001786.md) | [168](/filings/0000930413-26-002814.md) |
| Cost of revenue | $m | [182](/filings/0000930413-24-003270.md) | [157 d](/filings/0000930413-25-001069.md) | [147](/filings/0000930413-25-001941.md) | [128](/filings/0000930413-25-002856.md) | [135](/filings/0000930413-25-003566.md) | [141 d](/filings/0000930413-25-001069.md) | [144](/filings/0000930413-25-001941.md) | [144](/filings/0000930413-26-002814.md) | [139](/filings/0000930413-25-003566.md) | [129 d](/filings/0000930413-26-000937.md) | [135](/filings/0000930413-26-001786.md) | [134](/filings/0000930413-26-002814.md) |
| Gross profit | $m | [39.3](/filings/0000930413-24-003270.md) | [30.4 d](/filings/0000930413-26-000937.md) | [14.5](/filings/0000930413-25-001941.md) | [19.8](/filings/0000930413-25-002856.md) | [39.7](/filings/0000930413-25-003566.md) | [17.6 d](/filings/0000930413-26-000937.md) | [14.3](/filings/0000930413-26-001786.md) | [14.3](/filings/0000930413-26-002814.md) | [36.1](/filings/0000930413-25-003566.md) | [60.6 d](/filings/0000930413-26-002814.md) | [29.1](/filings/0000930413-26-001786.md) | [53.3](/filings/0000930413-26-002814.md) |
| Selling, general and administrative | $m | [7.6](/filings/0000930413-24-003270.md) | [7.4 d](/filings/0000930413-26-000937.md) | [6.1](/filings/0000930413-25-001941.md) | [6.4](/filings/0000930413-25-002856.md) | [8.4](/filings/0000930413-25-003566.md) | [6.2 d](/filings/0000930413-26-000937.md) | [5.9](/filings/0000930413-26-001786.md) | [6.2](/filings/0000930413-26-002814.md) | [8.2](/filings/0000930413-25-003566.md) | [12.3 d](/filings/0000930413-26-000937.md) | [9.7](/filings/0000930413-26-001786.md) | [15.6](/filings/0000930413-26-002814.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.6](/filings/0000930413-24-003270.md) | [7.2 d](/filings/0000930413-26-000937.md) | [3.7](/filings/0000930413-25-001941.md) | [4.5](/filings/0000930413-25-002856.md) | [9.4](/filings/0000930413-25-003566.md) | [3.8 d](/filings/0000930413-26-000937.md) | [3.0](/filings/0000930413-26-001786.md) | [2.8](/filings/0000930413-26-002814.md) | [8.0](/filings/0000930413-25-003566.md) | [7.9 d](/filings/0000930413-26-002814.md) | [4.4](/filings/0000930413-26-001786.md) | [7.5](/filings/0000930413-26-002814.md) |
| Net income | $m | [31.6](/filings/0000930413-23-002522.md) | [10.3 d](/filings/0000930413-24-001186.md) | [12.3](/filings/0000930413-25-002856.md) | [15.0](/filings/0000930413-25-002856.md) | [30.1](/filings/0000930413-25-003566.md) | [14.1 d](/filings/0000930413-26-000937.md) | [10.7](/filings/0000930413-26-002814.md) | [9.3](/filings/0000930413-26-002814.md) | [27.5](/filings/0000930413-25-003566.md) | [47.6 d](/filings/0000930413-26-000937.md) | [21.7](/filings/0000930413-26-002814.md) | [40.6](/filings/0000930413-26-002814.md) |
| Diluted EPS | $ per share | [1.49](/filings/0000930413-24-003270.md) | not reported | [0.58](/filings/0000930413-25-001941.md) | [0.70](/filings/0000930413-25-002856.md) | [0.69](/filings/0000930413-25-003566.md) | not reported | [0.26](/filings/0000930413-26-001786.md) | [0.22](/filings/0000930413-26-002814.md) | [0.71](/filings/0000930413-25-003566.md) | not reported | [0.56](/filings/0000930413-26-001786.md) | [1.06](/filings/0000930413-26-002814.md) |
| Basic EPS | $ per share | [1.49](/filings/0000930413-24-003270.md) | not reported | [0.58](/filings/0000930413-25-001941.md) | [0.71](/filings/0000930413-25-002856.md) | [0.70](/filings/0000930413-25-003566.md) | not reported | [0.26](/filings/0000930413-26-001786.md) | [0.22](/filings/0000930413-26-002814.md) | [0.71](/filings/0000930413-25-003566.md) | not reported | [0.56](/filings/0000930413-26-001786.md) | [1.06](/filings/0000930413-26-002814.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-31) | FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [72.8](/filings/0000930413-23-002522.md) | [223](/filings/0000930413-25-001069.md) | [231](/filings/0000930413-24-001828.md) | [261](/filings/0000930413-24-002683.md) | [298](/filings/0000930413-24-003270.md) | [196](/filings/0000930413-26-000937.md) | [160](/filings/0000930413-25-001941.md) | [241](/filings/0000930413-25-002856.md) | [272](/filings/0000930413-25-003566.md) | [189](/filings/0000930413-26-002814.md) | [118](/filings/0000930413-26-001786.md) | [91.3](/filings/0000930413-26-002814.md) |
| Current assets | $m | [418](/filings/0000930413-23-002522.md) | [452](/filings/0000930413-25-001069.md) | [422](/filings/0000930413-24-001828.md) | [419](/filings/0000930413-24-002683.md) | [436](/filings/0000930413-24-003270.md) | [436](/filings/0000930413-26-000937.md) | [399](/filings/0000930413-25-001941.md) | [391](/filings/0000930413-25-002856.md) | [412](/filings/0000930413-25-003566.md) | [448](/filings/0000930413-26-002814.md) | [442](/filings/0000930413-26-001786.md) | [458](/filings/0000930413-26-002814.md) |
| Total assets | $m | [628](/filings/0000930413-23-002522.md) | [665](/filings/0000930413-25-001069.md) | [671](/filings/0000930413-24-001828.md) | [680](/filings/0000930413-24-002683.md) | [716](/filings/0000930413-24-003270.md) | [720](/filings/0000930413-26-000937.md) | [694](/filings/0000930413-25-001941.md) | [701](/filings/0000930413-25-002856.md) | [750](/filings/0000930413-25-003566.md) | [798](/filings/0000930413-26-002814.md) | [808](/filings/0000930413-26-001786.md) | [856](/filings/0000930413-26-002814.md) |
| Current liabilities | $m | [48.7](/filings/0000930413-23-002522.md) | [66.3](/filings/0000930413-25-001069.md) | [62.7](/filings/0000930413-24-001828.md) | [51.9](/filings/0000930413-24-002683.md) | [44.0](/filings/0000930413-24-003270.md) | [50.4](/filings/0000930413-26-000937.md) | [42.6](/filings/0000930413-25-001941.md) | [37.1](/filings/0000930413-25-002856.md) | [57.5](/filings/0000930413-25-003566.md) | [75.4](/filings/0000930413-26-002814.md) | [65.3](/filings/0000930413-26-001786.md) | [66.5](/filings/0000930413-26-002814.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [493](/filings/0000930413-23-002522.md) | [514](/filings/0000930413-25-001069.md) | [524](/filings/0000930413-24-001828.md) | [540](/filings/0000930413-24-002683.md) | [564](/filings/0000930413-24-003270.md) | [560](/filings/0000930413-26-000937.md) | [536](/filings/0000930413-25-001941.md) | [546](/filings/0000930413-25-002856.md) | [567](/filings/0000930413-25-003566.md) | [611](/filings/0000930413-26-002814.md) | [629](/filings/0000930413-26-001786.md) | [674](/filings/0000930413-26-002814.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [58.8 d](/filings/0000930413-24-003270.md) | [62.5 d](/filings/0000930413-26-000937.md) | [(2.3)](/filings/0000930413-25-001941.md) | [8.0 d](/filings/0000930413-25-002856.md) | [33.4 d](/filings/0000930413-25-003566.md) | [25.1 d](/filings/0000930413-26-000937.md) | [(3.5)](/filings/0000930413-26-001786.md) | [16.3 d](/filings/0000930413-26-002814.md) | [51.2 d](/filings/0000930413-25-003566.md) | [53.8 d](/filings/0000930413-26-000937.md) | [(2.1)](/filings/0000930413-26-001786.md) | [40.1 d](/filings/0000930413-26-002814.md) |
| Capital expenditure | $m | [14.2 d](/filings/0000930413-24-003270.md) | [15.3 d](/filings/0000930413-26-000937.md) | [24.8](/filings/0000930413-25-001941.md) | [15.4 d](/filings/0000930413-25-002856.md) | [15.2 d](/filings/0000930413-25-003566.md) | [15.9 d](/filings/0000930413-26-000937.md) | [6.9](/filings/0000930413-26-001786.md) | [22.0 d](/filings/0000930413-26-002814.md) | [26.7 d](/filings/0000930413-25-003566.md) | [12.8 d](/filings/0000930413-26-000937.md) | [11.6](/filings/0000930413-26-001786.md) | [23.3 d](/filings/0000930413-26-002814.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0000930413-26-000937.md) | not reported | not reported | not reported | not reported | [32.7](/filings/0000930413-26-001786.md) | [0.7 d](/filings/0000930413-26-002814.md) | [0.0 d](/filings/0000930413-25-003566.md) | [0.0 d](/filings/0000930413-26-000937.md) | [0.0](/filings/0000930413-26-001786.md) | [1.6 d](/filings/0000930413-26-002814.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2017 (2017-04-30) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-31) | Q3 FY2023 (2023-10-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.6](/filings/0000930413-17-002268.md) | [17.4](/filings/0000930413-24-001828.md) | [17.5](/filings/0000930413-24-002683.md) | [17.5](/filings/0000930413-24-003270.md) | [17.7](/filings/0000930413-25-001941.md) | [17.7](/filings/0000930413-25-002856.md) | [35.4](/filings/0000930413-25-003566.md) | [33.9](/filings/0000930413-26-001786.md) | [33.0](/filings/0000930413-26-002814.md) | [33.0](/filings/0000930413-25-003566.md) | [33.1](/filings/0000930413-26-001786.md) | [33.1](/filings/0000930413-26-002814.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,175,640 at 2026-09-02, from the cover of the [10-Q filed 2026-09-03](/filings/0000930413-26-002814.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.